SEVEN EIGHT CAPITAL, LP - JUNO THERAPEUTICS INC ownership

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 243 filers reported holding JUNO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.8%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$2,081,000
+5376.3%
45,532
+4448.7%
0.21%
+1530.8%
Q2 2016$38,000
-60.0%
1,001
-60.0%
0.01%
-67.5%
Q1 2016$95,000
+13.1%
2,501
+31.6%
0.04%
-29.8%
Q4 2015$84,0001,901
+190000.0%
0.06%
Q3 2015$0
-100.0%
1
-100.0%
0.00%
-100.0%
Q2 2015$121,000
+3933.3%
2,268
+4436.0%
0.14%
+2760.0%
Q1 2015$3,000500.01%
Other shareholders

There were no reported owners of JUNO THERAPEUTICS INC in Q4 2017.

NameSharesValueWeighting ↓
View complete list of JUNO THERAPEUTICS INC shareholders